Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer
Biomolecules · 27.07.2024 · 14 (8) · 917
DOI: 10.3390/biom14080917 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 27.07.2024. Verfasst von Xueyuan Bi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, China. Hauptthemen laut MEDLINE: Gastrointestinal Neoplasms, Biomarkers, Tumor, Tumor Microenvironment. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Open Funds for Shaanxi Provincial Key Laboratory of Infection and Immune Diseases.
Abstract (Originalsprache)
Gastrointestinal (GI) cancers impose a substantial global health burden, highlighting the necessity for deeper understanding of their intricate pathogenesis and treatment strategies. This review explores the interplay between intratumoral microbiota, tumor metabolism, and major types of GI cancers (including esophageal, gastric, liver, pancreatic, and colorectal cancers), summarizing recent studies and elucidating their clinical implications and future directions. Recent research revealed altered microbial signatures within GI tumors, impacting tumor progression, immune responses, and treatment outcomes. Dysbiosis-induced alterations in tumor metabolism, including glycolysis, fatty acid metabolism, and amino acid metabolism, play critical roles in cancer progression and therapeutic resistance. The integration of molecular mechanisms and potential biomarkers into this understanding further enhances the prognostic significance of intratumoral microbiota composition and therapeutic opportunities targeting microbiota-mediated tumor metabolism. Despite advancements, challenges remain in understanding the dynamic interactions within the tumor microenvironment (TME). Future research directions, including advanced omics technologies and prospective clinical studies, offer promising avenues for precision oncology and personalized treatment interventions in GI cancer. Overall, integrating microbiota-based approaches and molecular biomarkers into GI cancer management holds promise for improving patient outcomes and survival.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.
- Institute of Medical Research, Northwestern Polytechnical University, Xi'an 710072, China.
- Department of Science and Education, Honghui Hospital, Xi'an Jiaotong University, Xi'an 710054, China.
Förderung
- Open Funds for Shaanxi Provincial Key Laboratory of Infection and Immune Diseases
Zitieren
APA
Bi, X., Wang, J., & Liu, C. (2024). Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer. Biomolecules, 14(8), 917. https://doi.org/10.3390/biom14080917
Vancouver
Bi X, Wang J, Liu C. Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer. Biomolecules. 2024;14(8):917. doi:10.3390/biom14080917
BibTeX
@article{Bi2024,
author = {Bi, Xueyuan and Wang, Jihan and Liu, Cuicui},
title = {Intratumoral Microbiota: Metabolic Influences and Biomarker Potential in Gastrointestinal Cancer},
journal = {Biomolecules},
year = {2024},
volume = {14},
number = {8},
pages = {917},
doi = {10.3390/biom14080917}
}
EUVIMED